Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Change in Accured Expenses: 2009-2024

Historic Change in Accured Expenses for Avadel Pharmaceuticals (AVDL) over the last 16 years, with Dec 2024 value amounting to $16.4 million.

  • Avadel Pharmaceuticals' Change in Accured Expenses fell 165.40% to -$4.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $227,000, marking a year-over-year decrease of 74.64%. This contributed to the annual value of $16.4 million for FY2024, which is 2.77% down from last year.
  • Avadel Pharmaceuticals' Change in Accured Expenses amounted to $16.4 million in FY2024, which was down 2.77% from $16.9 million recorded in FY2023.
  • In the past 5 years, Avadel Pharmaceuticals' Change in Accured Expenses ranged from a high of $16.9 million in FY2023 and a low of -$13.2 million during FY2020.
  • In the last 3 years, Avadel Pharmaceuticals' Change in Accured Expenses had a median value of $16.4 million in 2024 and averaged $11.2 million.
  • In the last 5 years, Avadel Pharmaceuticals' Change in Accured Expenses slumped by 3,804.76% in 2020 and then skyrocketed by 7,341.41% in 2023.
  • Avadel Pharmaceuticals' Change in Accured Expenses (Yearly) stood at -$13.2 million in 2020, then skyrocketed by 106.77% to $895,000 in 2021, then slumped by 74.64% to $227,000 in 2022, then skyrocketed by 7,341.41% to $16.9 million in 2023, then declined by 2.77% to $16.4 million in 2024.